Orchid Chemicals gets FDA nod for Levetiracetam tablets
Moneylife Digital Team 09 August 2010

Orchid Chemicals and Pharmaceuticals Ltd has received approval from the US Food and Drug Administration (USFDA) to sell levetiracetam tablets, 1,000 mg in that country. Levetiracetam is used in the treatment of epilepsy.

On Monday, Orchid Chemicals shares ended 0.8% up to Rs190 on the Bombay Stock Exchange, while the Sensex closed 0.7% up at 18,278 points.

Free Helpline
Legal Credit